You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Bulgaria

May 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Bulgaria with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Bulgaria, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Bulgaria for free:

The Consumer Health in Bulgaria market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Bulgaria?
  • What are the major brands in Bulgaria?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health largely unaffected by the recession

2010 remained a relatively successful year for consumer health in Bulgaria, in line with the unexpected high growth of Rx products. This was despite the effects of the global recession on Bulgaria as well as the US and other EU countries. Progress was driven by diversification, with new products with improved effects and growing awareness among consumers. Market stability in 2010 was due to the performance of the traditionally strong cough, cold and allergy (hay fever) remedies.

Consumers rely on advertising to learn about products

The review period showed how important marketing is to the development of consumer health in Bulgaria. Increasing popularity through advertising drove the growth of consumer health as new products were introduced and became popular as a result of marketing campaigns, resulting in high sales volumes. The most successful campaigns were those that educated consumers about the benefits of the given products, such as emergency contraception, as well as recommending one particular product. The drawback of this trend was the low control of advertising content which allowed some advertisers to make unsubstantiated claims about products of questionable quality.

Domestic manufacturers rely on exports as they are unable to compete with multinationals locally

The competitive landscape is characterised by a highly fragmented market, where only a couple of companies have larger shares and few of them are domestic manufacturers. Unless local players invest more in marketing and innovation, their shares will continue to decline. This is likely to continue as the financial resources of local companies is limited in comparison with multinationals. In an attempt to ensure higher growth, many domestic manufacturers rely on exporting their products to countries where Bulgarian products are traditionally well accepted, such as other Balkan countries and Russia.

The main distribution channel remains chemists/pharmacies

Distribution practices and habits changed little over the review period; chemists/pharmacies remained the key outlet for the distribution of consumer health products in Bulgaria. In spite of the legal issues related to the operation of chemists/pharmacies, it was positively influenced by overall retailing trends and became more focused on quality customer care. It introduced personnel who were able to assist and advise on a variety of consumer health products as well as Rx medication. Parapharmacies/drugstores became popular in Bulgaria but were not as popular as chemists/pharmacies in 2010. Direct selling is losing popularity in consumer health as its products are perceived as being of lower quality and without the benefit of qualified consultation being available at the time of purchase.

Consumer health is reaching maturity

Consumer health is expected to perform well over the forecast period but at a slower rate compared to the review period, since it is approaching maturity. Value sales, however, will be driven up by increasing product variation and sophistication. Another reason for a possible slowdown over the forecast period is expected to be the global financial crisis, although Bulgaria was not as seriously affected by it in the review period as other EU countries.

Table of Contents

Table of Contents

Consumer Health in Bulgaria - Industry Overview

EXECUTIVE SUMMARY

Consumer health largely unaffected by the recession

Consumers rely on advertising to learn about products

Domestic manufacturers rely on exports as they are unable to compete with multinationals locally

The main distribution channel remains chemists/pharmacies

Consumer health is reaching maturity

KEY TRENDS AND DEVELOPMENTS

New distribution channels emerge but chemists/pharmacies remains the leader in consumer health products

Marketing messages are well received by consumers and drive consumer health

2010 is a good year in spite of the recession

Dietary supplements and nutritionals registered as foods in order to avoid strict regulation

Bad eating habits and unhealthy lifestyles drive dietary supplements

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and preventative medicine

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Bulgaria - Company Profiles

Borola EOOD in Consumer Health (Bulgaria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Borola EOOD: Competitive Position 2010

Eurostok Bulgaria EOOD in Consumer Health (Bulgaria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Eurostok Bulgaria EOOD: Competitive Position 2010

Medica AD in Consumer Health (Bulgaria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Medica AD: Competitive Position 2010

Sopharma AD in Consumer Health (Bulgaria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Sopharma AD: Competitive Position 2010

Terrachim - Nikolay Kostov ET in Consumer Health (Bulgaria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Adult Mouth Care in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Current sales were the same as 2009 in 2010. The limited popularity of consumer adult mouth care is due to the intense competition from cosmetics and toiletries, which offer more sophisticated products with multiple effects. Better distribution of cosmetics and toiletries combined with limited advertising and marketing of adult mouth care further hampered growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • Tantum Verde remained the leading brand in 2010 with a 30% share. Its share declined steadily over the review period because the company stopped investing in advertising. Hexoral by Johnson & Johnson Bulgaria EOOD was the second most popular product with a 22% share.

PROSPECTS

  • Adult mouth care is expected to be driven by organic growth during the forecast period. Such growth is likely to be slow as adult mouth care is set to reach maturity and no significant growth is expected by the end of the forecast period.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 14 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Systemic analgesics remained the most popular consumer health analgesics type in Bulgaria in 2010. Analgin is the most popular systemic analgesic, mainly due to the long tradition of the Analgin brand in the country since its launch in 1954. It was the only systemic consumer health product on the market for a considerable period, therefore Analgin became synonymous with analgesics.

SWITCHES

COMPETITIVE LANDSCAPE

  • Actavis EAD remained in the leading position in 2010, retaining its share of 24% in value terms. Its main competitor, Sopharma, remained second with a share of 21%. Sopharma’s Analgin brand remained the most popular in analgesics in 2010.

PROSPECTS

  • Analgesics, although one of the most successful in consumer health in terms of value sales, is expected to see only moderate growth over the forecast period as it starts to reach maturity. In spite of the weakening positions of local manufacturers and intensive marketing campaigns by multinational companies, the local Analgin brand will continue to be the most popular analgesics brand as it is synonymous with pain relief for the majority of Bulgarians.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 20 Analgesics Company Shares by Value 2006-2010
  • Table 21 Analgesics Brand Shares by Value 2007-2010
  • Table 22 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Sales of calming and sleeping products reached BGN5 million in 2010, the same as in 2009. The best-sellers were the popular Validol, Glog-Menta-Valeriana and Valerian brands. The use of calming and sleeping products was stimulated by the increasingly hectic lifestyles of Bulgarians combined with increased awareness of and concern about the damage that stress can cause to the body

SWITCHES

COMPETITIVE LANDSCAPE

  • The leader in 2010 was Farmak VAT. The Ukrainian-based company held a 42% value share of calming and sleeping products in Bulgaria with its popular Validol brand. The product has been present for a long time and its name is synonymous with calming and sleeping products. However, its share declined during the review period as the shares of products such as Valerol and Anervina grew due to the novelty of the products.

PROSPECTS

  • Sales of calming and sleeping products are expected to register slight growth of 2% y-o-y over the forecast period. Demand for calming and sleeping products will be stimulated by increasingly intense everyday lifestyles but as it reaches maturity, and as more people turn to their doctors for advice on fighting stress (and doctors prescribe Rx medications), it is likely that growth will be adversely affected.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2005-2010
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 26 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 27 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • The growth rate remained positive in 2010 due to good consumer awareness and widespread advertising campaigns by the leading companies. The increased variety of products, rapid relief benefits and improved distribution were also important factors for the growth in sales of cough, cold and allergy (hay fever) remedies over the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Laboratoires UPSA remains the leader in 2010. The company owns two of the most popular brands, Fervex and Tyrcine. Boehringer Ingelheim Pharma GmbH & Co KG retained the second position. GlaxoSmithKline Plc, Novartis Pharma Services AG (Bulgaria), Engelhard Arzneimittel GmbH & Co KG and Johnson & Johnson Bulgaria EOOD are the other major market players with shares of 5% and above. The shares of the remaining companies are insignificant.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies retained its good position in 2010 but will start reaching maturity over the forecast period. The period of educating consumers has passed and the market is already shaped. Although new players could be expected, the financial crisis and its after-effects on the Bulgarian market are likely to impede newcomers over the forecast period.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 32 Sales of Decongestants by Category: Value 2005-2010
  • Table 33 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 34 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Despite growing awareness, Bulgarians do not pay enough attention to their eating habits, which are traditionally bad. In spite of increasing disposable incomes, more hectic lifestyles and unbalanced diets are leading to serious digestion problems, as well as weight issues.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Chinoin remained the market leader in digestive remedies in 2010 with a share of just above 15% of the market. Berlin CHemie AG was a very close second with a share of 14%. Actavis Bulgaria remains the third most influential company with a value share of just above 14%. There were no significant changes in share during the review period.

PROSPECTS

  • Digestive remedies is not expected to grow at a significant rate over the forecast period due to approaching maturity. Furthermore, slimming products became more popular in Bulgaria over the review period, drawing attention away from digestive remedies. The latter is not well advertised, either at brand or category level.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 42 Digestive Remedies Company Shares by Value 2006-2010
  • Table 43 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • OTC ear care sales were stable in 2010, registering only slight growth of less than 1% in constant terms in 2010. The negligible level of value sales was attributed to the limited number of consumer health products available and the strong competition from Rx products. Consumers with ear problems avoid purchasing any product before consulting a doctor, who typically recommends Rx products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Local manufacturer Sopharma was the key player in ear care with an 80% value share in 2010. Ear care seems unattractive even for large multinational players and they prefer to develop Rx medicines which have greater potential for generating value sales.

PROSPECTS

  • The expected limited growth and low base indicate that its progress will be insignificant over the forecast period. It will remain undeveloped and value sales are not expected to exceed BGN600,000 over the forecast period.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2005-2010
  • Table 47 Sales of Ear Care: % Value Growth 2005-2010
  • Table 48 Ear Care Company Shares by Value 2006-2010
  • Table 49 Ear Care Brand Shares by Value 2007-2010
  • Table 50 Forecast Sales of Ear Care: Value 2010-2015
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Emergency contraception sales in Bulgaria reached BGN1 million in 2010. This figure was driven by Escapelle, a product from the Hungarian company Richter Gedeon Ltd, launched in 2006. The launch was supported by a widespread marketing campaign which included TV, radio, billboard and magazine advertisements and sponsorships. This not only made the product popular, but also created consumer awareness of emergency contraception products, their usage and properties. The campaign is regularly repeated, thus ensuring sales growth.

CATEGORY DATA

  • Table 52 Sales of Emergency Contraception: Value 2005-2010
  • Table 53 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 54 Emergency Contraception Company Shares by Value 2006-2010
  • Table 55 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 56 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 57 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • In 2010, eye care sales remained the same as in 2009 at BGN2 million. Eye care remained underdeveloped due to the strong competition from Rx eye care products. Local consumers rarely purchase consumer eye care products and prefer to consult a doctor for Rx eye care products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Galena as was the leader in Bulgarian eye care in 2010 with a 29% value share. Johnson & Johnson Bulgaria EOOD was second with 24% of value sales. The company was not present in eye care until 2007 but gained its high ranking following the acquisition of Visine from Pfizer Laboratories Korea Ltd. There are no local manufacturers of consumer eye care products in Bulgaria in 2010.

PROSPECTS

  • Consumer eye care is undeveloped, and it is to record only marginal growth over the forecast period. Unlike Rx products, consumer health products are not considered necessary by customers but more of a luxury, therefore becoming an item that people tend to save on in times of financial crisis.

CATEGORY DATA

  • Table 58 Sales of Eye Care by Category: Value 2005-2010
  • Table 59 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 60 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 61 Eye Care Company Shares by Value 2006-2010
  • Table 62 Eye Care Brand Shares by Value 2007-2010
  • Table 63 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 64 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional dietary supplements is the best-seller in herbal/traditional products. The mild effect of the herbal ingredients is preferred by consumers since dietary supplements are generally taken over the course of several weeks or even months.

COMPETITIVE LANDSCAPE

  • There were no new launches of herbal/traditional products in 2010 due to the financial crisis which affected consumer spending.

PROSPECTS

  • Herbal/traditional products are likely to show positive growth of 3% over the forecast period. Consumer awareness and health concerns, combined with the latest trends of using bio products, are the general prerequisites that will shape the market.

CATEGORY DATA

  • Table 65 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 66 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 67 Herbal/Traditional Products Company Shares 2006-2010
  • Table 68 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 69 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 70 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • The growth rate in 2010 was negative compared to the positive development recorded over the entire review period. Growth was due to consumers switching from cosmetics and toiletries products to medicated skin care in order to treat specific problems, such as dandruff. However, with more purely cosmetic solutions appearing which promise similar results at lower prices, consumers prefer those offers to medicated skin care products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sopharma was the leading company in medicated skin care between 2001-2008, although its share declined between 2008-2010. Its strong position was based on the popularity of its Allergosan brand. However, in 2010 the company was second, and the leader was Johnson & Johnson Bulgaria EOOD due to the popularity of the Nizoral brand. The popularity of these products is due to the fact that they treat two of the most common skin problems, dandruff and general allergic reactions. The remaining companies and brands have insignificant shares and little influence in medicated skin care.

PROSPECTS

  • Although medicated skin care remains underdeveloped in Bulgaria, it is not expected to show significant progress over the forecast period. The relatively low demand and competition from cosmetics and toiletries, as well as the effect of the financial crisis which caused many consumers to limit their expenses on products that they do not consider an absolute necessity, are expected to reduce performance.

CATEGORY DATA

  • Table 71 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 72 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 73 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 74 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 75 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 76 Acne Treatments Brand Shares by Value 2007-2010
  • Table 77 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 78 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids remained one of the least developed in Bulgarian consumer health in 2010. The products were neglected by potential consumers as the number of smokers in Bulgaria is amongst the highest in the EU, and many consider smoking as a freedom of choice that they do not wish to give up, rather than an unhealthy habit. In 2010, a third of the Bulgarian population were smokers. This number increased in spite of anti-smoking campaigns and government restrictions, which are often ignored.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pharmacia Corp was the leader in 2010 with a value share of 44% due to its Nicorette brand. It was the first NRT smoking cessation aid launched locally and the company took advantage of that. Novartis AG occupied second position, and Fertin A/S was third. In 2010 there are no other significant players as the market is quite small and is not attractive enough due to low levels of sales.

PROSPECTS

  • Growth was slow in 2010 but is expected to improve in the forecast period. The growth in 2010 was hampered by the reversal in the decision to impose the smoking ban in public place, due to concerns by the foodservice industry. Therefore, instead of adopting a complete ban, the Bulgarian government introduced stricter regulation of premises with separate rooms for smokers and non-smokers. A full ban is expected by the end of the forecast period, but the habits of Bulgarian smokers are likely to change much more slowly. It is therefore not expected that changes in legislation will have an immediate effect on NRT smoking cessation aids within the forecast period.

CATEGORY INDICATORS

  • Table 79 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 80 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 81 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 82 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 83 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 84 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 85 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 86 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Most sports nutrition brands in Bulgaria are imported, with few local producers. The number of consumers was still limited in 2010, however products of all formats and ingredients were available. Sports nutrition in Bulgaria is therefore comparable to other EU countries. The products were additionally popularised by the increasing number of websites which publish sports articles and balanced eating tips.

COMPETITIVE LANDSCAPE

  • Musashi Bulgaria, Nutrim OOD and Biogame OOD are among the leaders in sports nutrition because their products are well advertised, effectively distributed to key retail chains or fitness clubs and considered to be of premium quality.

PROSPECTS

  • Sales are expected to grow by about 3% over the forecast period, mostly due to the effect of the financial crisis which may still be felt in 2015. Sports nutrition will generate sales and retain its popularity due to increasingly hectic and sedentary lifestyles which will be the major driver of the popularity of fitness clubs and of sports nutrition as a consequence.

CATEGORY DATA

  • Table 87 Sales of Sports Nutrition: Value 2005-2010
  • Table 88 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 89 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 90 Sports Nutrition Company Shares 2006-2010
  • Table 91 Sports Nutrition Brand Shares 2007-2010
  • Table 92 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 93 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Until relatively recently vitamins and dietary supplements was very underdeveloped, but between 2005-2008 it grew very quickly, due to the increasing disposable incomes of Bulgarians and their growing concern for a healthy lifestyle and illness prevention. Manufacturers responded to the growing demand by launching a large number of new products, aided by loose registration procedures and unrestricted advertising. This freedom allowed some companies to launch products which did not have the advertised qualities. According to the Bulgarian authorities, most were harmless and there were no serious accidents with the products due to strengthened control.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Actavis EAD was the leader in Bulgarian vitamins and dietary supplements with a 13% value share in 2010. Walmark sro was in second position. The third position in 2010 was occupied by local company Kendy Bulgaria OOD with a 10% share.

PROSPECTS

  • As the market progresses, consumer demand and preferences change. More consumers pay attention to the quality of the purchased products, and are likely to turn to higher-end and sophisticated vitamins and dietary supplements.

CATEGORY DATA

  • Table 94 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 95 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 96 Dietary Supplements by Positioning 2005-2010
  • Table 97 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 98 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 99 Vitamins Brand Shares by Value 2007-2010
  • Table 100 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 101 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 102 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Walmark and United Traders OOD were in intense competition during the review period with their respective popular products Clarinol 1000 and Regulavit. In 2009 United Traders OOD increased its share to occupy first position, although it had a very marginal lead over its competitor. This was due to its marketing efforts combined with word-of-mouth. The company maintained the leading position in 2010.

COMPETITIVE LANDSCAPE

  • Weight management remains highly fragmented. Walmark and United Traders OOD are the leaders in value sales. GM Pharma, Vita Gold OOD and Borola EOOD are the other major companies in weight management. There are other small manufacturers and importers which do not invest heavily in marketing and rely mainly on impulse purchases or word-of-mouth.

PROSPECTS

  • Although weight management products are popular and perform well, there was a slowdown in sales in 2009 which is expected to continue over the forecast period. The reasons are the financial crisis not having subsided completely, as well as the controversial products of lower quality harming the image of weight management. This is expected to cause consumers to turn to other forms of weight management, such as fitness. Major players are expected to further stabilise their positions and gain share at the expense of small manufacturers and importers.

CATEGORY DATA

  • Table 103 Sales of Weight Management: Value 2005-2010
  • Table 104 Sales of Weight Management: % Value Growth 2005-2010
  • Table 105 Weight Management Company Shares 2006-2010
  • Table 106 Weight Management Brand Shares 2007-2010
  • Table 107 Forecast Sales of Weight Management: Value 2010-2015
  • Table 108 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Bulgaria - Category Analysis

HEADLINES

TRENDS

  • Wound care showed very little growth in 2010, remaining at BGN4 million in current value terms. The increase was attributed to organic growth, and particularly to constant product diversification. The inconsistency of growth rates over the review period is an indication of maturity.

COMPETITIVE LANDSCAPE

  • The local manufacturer Medica AD was the leader in 2010 with a value share of 43%. The success of the company is due to its multiple brand strategy. Cytoplast, Sanplast and Bandage Medika 5/10 have been available for many years and are well known by the population. The company also constantly improves the properties of its products and maintains a high quality level. Laboratoires Urgo was the other major player in wound treatments, occupying second place with a 17% share.

PROSPECTS

  • The sector is expected to register slow growth over the forecast period. Sticking plasters/adhesive bandages is expected to have the highest sales during the forecast period while gauze, tape and other wound care is expected to show higher constant value growth due to its low base. However, wound care has reached maturity; therefore no significant growth is expected by 2015.

CATEGORY DATA

  • Table 109 Sales of Wound Care by Category: Value 2005-2010
  • Table 110 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 111 Wound Care Company Shares by Value 2006-2010
  • Table 112 Wound Care Brand Shares by Value 2007-2010
  • Table 113 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 114 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Isoflavones
            • Microalgae
            • Saccharinum
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • L-Carnitine
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking incidence

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Future Demographic

Country Report

Consumer Lifestyle

Country Report